Gujarat Kidney & Super Speciality's Q2 FY 2026-27 Quarterly Results

Result Summary

• Gujarat Kidney & Super Speciality Ltd reported a 10.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 197.1%.
• Its expenses for the quarter were up by 7.3% QoQ and 234.3% YoY.
• The net profit increased 24.1% QoQ and increased 129.2% YoY.
• The earnings per share (EPS) of Gujarat Kidney & Super Speciality Ltd stood at 0.74 during Q2 FY 2026-27.

Financial Statments for Q2 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Gujarat Kidney & Super Speciality Ltd is a healthcare company that primarily operates in the medical industry, focusing on providing specialized healthcare services. The company’s offerings likely include renal care and other super-specialty medical services, although specific details about the scope of services are not available in the provided data. Recent major developments or strategic changes within the company remain unspecified. The company operates in a sector that is crucial for providing critical healthcare services, a field characterized by continuous demand and growth.

Revenue

In Q2FY27, Gujarat Kidney & Super Speciality Ltd reported a total income of ₹38.68 crores, marking a significant quarter-over-quarter increase of 10.6% from Q1FY27, where the total income was ₹34.98 crores. The year-over-year growth is even more pronounced, with a 197.1% increase from Q2FY26's total income of ₹13.02 crores. This substantial growth in revenue over both the quarterly and yearly periods points to an expansion in the company's operations or an increase in service uptake. The financial data provided does not include details about specific revenue streams or the factors contributing to this growth.

Profitability

The company's profitability has shown considerable improvement over both the quarterly and yearly periods. Profit before tax for Q2FY27 stood at ₹8.62 crores, showing a 23.9% increase over the previous quarter (Q1FY27: ₹6.96 crores) and a 113.9% increase from the same quarter last year (Q2FY26: ₹4.03 crores). After accounting for taxes, the profit after tax in Q2FY27 was ₹6.60 crores, which is a 24.1% increase from Q1FY27's ₹5.32 crores and a 129.2% increase from ₹2.88 crores in Q2FY26. The tax expenses also increased, aligning with the growth in profitability, with a 23.8% increase from the previous quarter and a 76.5% increase year-over-year.

Operating Metrics

The operating metrics highlight a substantial increase in earnings per share (EPS), which rose to ₹0.74 in Q2FY27 from ₹0.66 in Q1FY27, reflecting a 12.1% quarter-over-quarter growth. Compared to Q2FY26, when EPS was ₹0.47, there is a year-over-year increase of 57.4%. The total expenses for Q2FY27 were ₹30.05 crores, which is a 7.3% increase from the previous quarter’s ₹28.01 crores and a significant 234.3% increase from the ₹8.99 crores recorded in Q2FY26. The rise in expenses could be attributed to scaling operations or increased operational costs, though specific causes are not detailed in the provided data.